🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, open-label, multi-center study evaluating t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01137994
Treatments Being Tested
This is a randomized controlled trial of HER-2 positive breast cancer patie...
Status
Unknown
Location
PUMCH
Start Date
2017-03-01
Trial ID
NCT03085368
Treatments Being Tested
This study is an open-label, dose-escalation study of MM-111 with five diff...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2011-01
Trial ID
NCT01304784
This study was designed to be two-part study (Phase I/Phase II). Part I was...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-09-26
Trial ID
NCT00251433
Treatments Being Tested
This was a four-arm (parallel group) randomized, open-label, multicenter Ph...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-05-16
Trial ID
NCT00490139
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, fluorouracil, epi...
Status
Completed
Location
C.H.U. Sart-Tilman
Start Date
2007-02
Trial ID
NCT00450892
Treatments Being Tested
Phase II randomized multicenter trial to compare Epirubicin and Cyclophosph...
Status
Completed
Location
Hospital Germans Trias i Pujol
Start Date
2009-02
Trial ID
NCT00841828
Treatments Being Tested
The primary objective: -To assess the efficacy of TCH and TCHL in neo-adju...
Status
Completed
Location
St James's Hospital
Start Date
2010-10
Trial ID
NCT01485926
Treatments Being Tested
This trial combines dose dense chemotherapy with doxorubicin and cyclophosp...
Status
Completed
Location
Santa Clara Valley Medical Center
Start Date
2006-10
Trial ID
NCT00404066
Treatments Being Tested
Anthracycline-taxane based chemotherapy regimens are recommended mainly by ...
Status
Completed
Location
Universitätsfrauenklinik Frankfurt / Main
Start Date
2007-10
Trial ID
NCT00567554